RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues

Scottsdale, AZ – August 14, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the Company’s novel medical device to now spray all varieties of tissues and cells, thus opening the door for its potential application in the regeneration of tissues and organs, beyond skin.